Reschke, M.; Salvador, E.; Schlegel, N.; Burek, M.; Karnati, S.; Wunder, C.; Förster, C.Y.
Isosteviol Sodium (STVNA) Reduces Pro-Inflammatory Cytokine IL-6 and GM-CSF in an In Vitro Murine Stroke Model of the Blood–Brain Barrier (BBB). Pharmaceutics 2022, 14, 1753.
https://doi.org/10.3390/pharmaceutics14091753
AMA Style
Reschke M, Salvador E, Schlegel N, Burek M, Karnati S, Wunder C, Förster CY.
Isosteviol Sodium (STVNA) Reduces Pro-Inflammatory Cytokine IL-6 and GM-CSF in an In Vitro Murine Stroke Model of the Blood–Brain Barrier (BBB). Pharmaceutics. 2022; 14(9):1753.
https://doi.org/10.3390/pharmaceutics14091753
Chicago/Turabian Style
Reschke, Moritz, Ellaine Salvador, Nicolas Schlegel, Malgorzata Burek, Srikanth Karnati, Christian Wunder, and Carola Y. Förster.
2022. "Isosteviol Sodium (STVNA) Reduces Pro-Inflammatory Cytokine IL-6 and GM-CSF in an In Vitro Murine Stroke Model of the Blood–Brain Barrier (BBB)" Pharmaceutics 14, no. 9: 1753.
https://doi.org/10.3390/pharmaceutics14091753
APA Style
Reschke, M., Salvador, E., Schlegel, N., Burek, M., Karnati, S., Wunder, C., & Förster, C. Y.
(2022). Isosteviol Sodium (STVNA) Reduces Pro-Inflammatory Cytokine IL-6 and GM-CSF in an In Vitro Murine Stroke Model of the Blood–Brain Barrier (BBB). Pharmaceutics, 14(9), 1753.
https://doi.org/10.3390/pharmaceutics14091753
